PRostate Cancer Plasma Integrative Multi-modal Evaluation

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Metastatic Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Analysis of cell free DNA, and extracellular vesicles (EVs) and EV-associated molecular components (including RNA, DNA, proteins)

"Plasma and buffy coat samples are shipped from the recruiting clinical sites to the lab of Professor Francesca Demichelis at the University of Trento (UniTN).~At UniTN, samples are stored in dedicated freezers with restricted access and subsequently used as follows:~* the plasma is used for the isolation of cell free DNA and extracellular vesicles (EVs);~* the buffy coat is used for the extraction of genomic DNA.~Nucleic acids sequencing library preparations and all downstream omics analyses are performed by Prof. Demichelis team."

Trial Locations (4)

10043

RECRUITING

Azienda Ospedaliera San Luigi, Orbassano

35128

RECRUITING

Istituto Oncologico Veneto, Padua

38122

RECRUITING

Santa Chiara Hospital, Trento

47014

RECRUITING

Istituto Romagnolo per lo Studio dei Tumori, Meldola

All Listed Sponsors
collaborator

Università degli Studi di Trento

OTHER

lead

Santa Chiara Hospital

OTHER